Suzhou Ersheng Biomedical was established at the end of December 2021 and is located in the beautiful Suzhou Industrial Park Biomedical Industrial Park Biobay. The company has made many breakthrough original achievements in the fields of cancer vaccines based on whole cell antigen of cancer cells, cancer immunotherapy based on tumor antigen-specific T cells, peripheral blood tumor antigen-specific T cell detection, and mRNA vaccine delivery. The relevant core patents have been authorized domestically, and have entered countries and regions such as the United States, Japan, the European Union, Canada, Australia, South Korea, and Brazil. The company's mission is to help conquer the last mile of cancer and accelerate the 100 meter run. It focuses on the research and development of original innovative drugs, treatment methods, and detection technologies, hoping to develop into a technologically advanced enterprise in the field of cancer treatment and T cell therapy worldwide.